Hox-4A: Key Regulator of Neural Development and Potential Drug Target

Target Name: HOXD3

NCBI ID: G3232

HOXD3

Hox-4A: Key Regulator of Neural Development and Potential Drug Target

Homeobox proteins (Hox) are a family of genes that play a crucial role in the development and maintenance of normal tissue structure and function. One of the most well-studied Hox genes is Hox-4A, which is a key regulator of neural development and has been implicated in a number of diseases. In this article, we will explore the biology of Hox-4A and its potential as a drug target.

Structure and Function

Hox-4A is a 21-kDa protein that is expressed in a variety of tissues, including neural cells, muscle cells, and epithelial cells. It is composed of a unique N-terminal region that contains a conserved N-acetyl-Lys-Glu (NALG) domain, a central region that contains a putative nuclear localization domain (NLD), and a C-terminal region that contains a T-loop and a leucinerich repeat (LRR) domain.

The NALG domain is a common feature of Hox proteins and is involved in the formation of a disulfide bond that connects the N-terminus of the protein to the C-terminus. This feature is important for the stability of the protein and its ability to function as a gene repressor. The central region of Hox-4A contains a putative nuclear localization domain (NLD), which is thought to play a role in the nuclear localization of the protein. The NLD is composed of a variety of conserved and unique amino acids that are involved in the formation of a nuclear localization signal (NLS).

The C-terminus of Hox-4A contains a T-loop and a leucinerich repeat (LRR) domain. The T-loop is a conserved region that is involved in the formation of a disulfide bond and is thought to play a role in the stability of the protein. The LRR domain is a unique and conserved region that is involved in the formation of a hydrogen bond with the NALG domain and is thought to be involved in the regulation of gene expression.

Hox-4A is involved in a number of cellular processes that are important for normal development and maintenance. For example, it is involved in the regulation of neuronal differentiation and in the development of neural tissue. It is also involved in the regulation of cell cycle progression and in the maintenance of stem cell properties. In addition, Hox-4A is implicated in the development of a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Drug Target Potential

Hox-4A is a potential drug target due to its involvement in a number of diseases. Its involvement in the regulation of neural development and its role in the development of cancer make it an attractive target for small molecule inhibitors. In addition, Hox-4A's involvement in the regulation of cell cycle progression and its role in the maintenance of stem cell properties make it an attractive target for agents that promote apoptosis.

One potential drug that targets Hox-4A is a small molecule inhibitor called JS011265. This compound is currently being tested in a clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's disease. According to the results of these trials, JS011265 appears to be effective in reducing the neurodegeneration caused by these diseases and may be a useful treatment for these conditions.

Another potential drug that targets Hox-4A is a small molecule inhibitor called Fasorbin. This compound is being tested in a clinical trial for the treatment of cancer. According to these results, Fasorbin appears to be effective in inhibiting the growth of cancer cells and may be a useful treatment for this condition.

Conclusion

In conclusion, Hox-4A is a key regulator of neural development and is involved in a number of diseases. Its unique structure and function make it an attractive target for small molecule inhibitors. Currently, there are several compounds that are being tested in clinical trials that target Hox-4A, including JS011265 and Fasorbin. These compounds may be useful treatments for a variety of conditions, including neurodegenerative diseases and cancer. Further research is needed to fully understand the biology of Hox-4A and its potential as a drug target.

Protein Name: Homeobox D3

Functions: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

The "HOXD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets